Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine | ACS Pharmacology & Translational Science
Advancing the Adverse Outcome Pathway for PPARγ Inactivation Leading to Pulmonary Fibrosis Using Bradford-Hill Consideration and the Comparative Toxicogenomics Database | Chemical Research in Toxicology